Home › NCT06414278

Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy

Early Identification of Cognitive Side-Effects of Immunotherapy

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* \* ≥ 18 years of age at initiation of therapy

  * Planning to undergo inpatient CAR-T therapy for primary malignancy
  * Fluent in English (written or spoken)

Exclusion Criteria:

* \* Subjects with speech or hearing impediment that would make them unable to be assessed with SALSA

  * Subjects with diagnosed cognitive impairment prior to CAR-T therapy
  * Unwilling or unable to sign voluntary written consent

About the study

This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.

What is being tested

• Non-Interventional Study (other)

Sponsor: Masonic Cancer Center, University of Minnesota · Participants: 38 · Started: Feb 8, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06414278

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.